amodiaquine

also known as Amodiaquin · Amodiaquina · Amodiaquine dihydrochloride dihydrate · Amodiaquine hcl · AMODIAQUINE HYDROCHLORIDE · Amodiaquine hydrochloride dihydrate · Amodiaquini hydrochloridum · Amodiaquinum · +8 more

Other / unclassified

Developed for: malaria · Plasmodium falciparum malaria · anemia · Plasmodium vivax malaria · COVID-19
Investigated by: London School of Hygiene and Tropical Medicine · Sanofi · Centers for Disease Control and Prevention · University of Oxford · Cheikh Anta Diop University, Senegal · Malaria Consortium
+115 more
· Centre Muraz · Heidelberg University · Institute of Tropical Medicine, Belgium · Kintampo Health Research Centre, Ghana · Mahidol Oxford Tropical Medicine Research Unit · Mahidol University · Malaria Research and Training Center, Bamako, Mali · Medicines for Malaria Venture · University of California, San Francisco · University of Yaounde 1 · Wellcome Trust · World Health Organization · Bill and Melinda Gates Foundation · Department for International Development, United Kingdom · Epicentre · Institut de Recherche pour le Developpement, Senegal · Kamuzu University of Health Sciences · Kenya Medical Research Institute · Kwame Nkrumah University of Science and Technology · Liverpool School of Tropical Medicine · Makerere University · Medecins Sans Frontieres, Spain · Medical Research Council · Ministry of Health, Ghana · Ministry of Health, Malawi · Ministry of Health, Senegal · Ministry of Public Health, Democratic Republic of the Congo · National Institute of Allergy and Infectious Diseases (NIAID) · National Malaria Control Program · University of Kinshasa · Uppsala University · Academic Medical Center - University of Amsterdam · Albert Schweitzer Hospital · Alliance for International Medical Action · Alliance médicale contre le paludisme, Mali · Armauer Hansen Research Institute, Ethiopia · Association Camerounaise pour le Marketing Social (ACMS), Cameroon · Bandim Health Project · Biotechnology Center (BTC), University of Yaounde I, Cameroon · Center for International Health and Development · Centre de Recherche en Sante de Nouna, Burkina Faso · Centre for Global Health Research, Ghana · Centre national de recherche et de formation sur le paludisme · Charite University, Berlin, Germany · Communities · Department of State for Health and Social Welfare, The Gambia · Developing Excellence in Leadership, Training and Science Africa Initiative · Disease Control, Department of Health, Myanmar · Division Controle Medicale Scolaire, Ministry of Education, Senegal · East African Network for Monitoring Antimalarial Treatment · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · European Commission · European and Developing Countries Clinical Trials Partnership (EDCTP) · French National Institute of Health and Medical Research · Fund for Scientific Research, Flanders, Belgium · Gates Malaria Partnership · Harvard University · HealthNet TPO · INDEPTH Network · Impact Malaria, Cameroon · Infectious Diseases Research Collaboration, Uganda · Institut National d'Etude et d'Action pour le Developpement de l'Education, Senegal · Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo · Institut Pasteur · Institut Pasteur de Madagascar · Institut de Recherche en Sciences de la Sante, Burkina Faso · Institute for Research and Development of Medicinal and Food Plants of Guinea · Karolinska University Hospital · Malaria Consortium, UK · Malaria Control Program, Directorate of Malaria Control, Pakistan · Malaria Research Capacity Development in West and Central Africa Consortium · Manhiça Health Research Centre · Mbarara University of Science and Technology · Medecins Sans Frontieres, Netherlands · all 121 on the full record

Trials 81 · started per year

today

2001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 14 trials
Phase 1	NCT04080895	Nov 2022 → Apr 2025	—	University of Oxford	Terminated	No outcome recorded
Phase 1	NCT04002687	Apr → Oct 2019	malaria	Medicines for Malaria Venture	Completed	No outcome recorded
Phase 1	NCT02242799	Jun 2015 → Sep 2016	HIV infectious disease, malaria	University of Liverpool	Completed	No outcome recorded
Phase 1	NCT00386503	Jun → Dec 2006	malaria	Sanofi	Completed	No outcome recorded
Phase 1/23 trials
Phase 1/2	NCT02696954	Nov 2016 → Mar 2019	—	University of Oxford	Terminated	No outcome recorded
Phase 1/2	NCT01319448	Sep 2011 → Apr 2013	malaria, sickle cell disease	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 1/2	NCT01328990	Apr → Jul 2011	malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 27 trials · 1 met primary
Phase 2	NCT05550909	Oct → Dec 2022	Plasmodium falciparum malaria	London School of Hygiene and Tropical Medicine	Completed	Mixed
Phase 2	NCT05081089	Oct → Dec 2021	Plasmodium falciparum malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 2	NCT04532931	Sep 2020 → Aug 2021	COVID-19	Shin Poong Pharmaceutical Co. Ltd.	Completed	No outcome recorded
Phase 2	NCT04502342	Jun → Aug 2020	COVID-19	Institute for Research and Development of Medicinal and Food Plants of Guinea	Unknown	No outcome recorded
Phase 2	NCT02831023	Jul 2016 → Jan 2017	malaria	University of California, San Francisco	Completed	Met primary
Phase 2	NCT00354380	Sep → Nov 2006	malaria	Heidelberg University	Completed	No outcome recorded
Phase 2	NCT00261222	Sep → Nov 2005	malaria	Heidelberg University	Completed	No outcome recorded
Phase 2/35 trials · 1 met primary
Phase 2/3	NCT05764746	May 2023 → Dec 2024	Plasmodium falciparum malaria	Muhimbili University of Health and Allied Sciences	Completed	No outcome recorded
Phase 2/3	NCT00561899	Aug 2007 → Feb 2008	malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 2/3	NCT00119132	Jun 2005 → Dec 2006	malaria	London School of Hygiene and Tropical Medicine	Completed	Met primary
Phase 2/3	NCT00146783	Jun 2004 → Feb 2007	malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 2/3	NCT00146718	Aug 2003 → May 2005	malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 321 trials · 9 met primary · 1 missed
Phase 3	NCT05951595	Sep 2025 → Jul 2026 overdue	Plasmodium falciparum malaria	University of Oxford	Recruiting	No outcome recorded
Phase 3	NCT06923592	May 2025 → Apr 2027 expected	Plasmodium falciparum malaria, Plasmodium vivax malaria	London School of Hygiene and Tropical Medicine	Recruiting	No outcome recorded
Phase 3	NCT05946642	Jul 2023 → May 2024	malaria	Malaria Consortium	Unknown	No outcome recorded
Phase 3	NCT05471544	Jul 2022 → Dec 2024	malaria	Malaria Consortium	Unknown	No outcome recorded
Phase 3	NCT03923725	Sep 2020 → Mar 2024	Plasmodium falciparum malaria	University of Oxford	Completed	No outcome recorded
Phase 3	NCT03355664	Mar 2018 → Mar 2020	Plasmodium falciparum malaria	University of Oxford	Completed	Missed primary
Phase 3	NCT01374581	May 2012 → Jun 2014	malaria	University of Antwerp	Completed	No outcome recorded
Phase 3	NCT01378286	Jan 2012 → Jun 2013	malaria	Sanofi	Completed	Met primary
Phase 3	NCT01449045	Jul → Dec 2011	malaria	Cheikh Anta Diop University, Senegal	Completed	Met primary
Phase 3	NCT01845701	Mar 2010 → Apr 2014	malaria	University of Yaounde 1	Completed	Met primary
Phase 3	NCT00393679	Jul 2007 → Dec 2009	malaria	Institute of Tropical Medicine, Belgium	Completed	Mixed
Phase 3	NCT00432367	Feb 2007 → Feb 2009	anemia, malaria, pregnancy disorder	London School of Hygiene and Tropical Medicine	Completed	Met primary
Phase 3	NCT00316329	Mar 2006 → ?	Plasmodium falciparum malaria	Sanofi	Completed	Met primary
Phase 3	NCT00142246	Jan 2005 → Apr 2006	Plasmodium falciparum malaria	London School of Hygiene and Tropical Medicine	Completed	Met primary
Phase 3	NCT00123552	Nov 2004 → Jun 2006	malaria	University of California, San Francisco	Completed	Met primary
Phase 3	NCT00406146	Oct 2004 → Dec 2006	malaria	University of Ghana Medical School	Unknown	No outcome recorded
Phase 3	NCT00132548	Jun → Dec 2004	malaria	London School of Hygiene and Tropical Medicine	Completed	Met primary
Phase 3	NCT00146731	Jan 2004 → Sep 2007	malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 3	NCT00118807	Aug 2003 → Feb 2004	Plasmodium falciparum malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 3	NCT00131703	Mar 2003 → Mar 2005	malaria, pregnancy disorder	London School of Hygiene and Tropical Medicine	Completed	Met primary
Phase 3	NCT00158548	Jun 2001 → Dec 2004	Plasmodium falciparum malaria, Plasmodium vivax malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded

Phase 430 trials · 1 met primary · 2 missed
Phase 4	NCT07322068	Sep 2026 → Jun 2033 expected	Plasmodium falciparum malaria	Stanford University	Not yet recruiting	No outcome recorded
Phase 4	NCT06967519	Dec 2025 → Dec 2027 expected	HIV infectious disease, malaria	Yale University	Recruiting	No outcome recorded
Phase 4	NCT06083688	Oct 2024 → Jul 2025 overdue	Plasmodium falciparum malaria, anemia	Liverpool School of Tropical Medicine	Active not recruiting	No outcome recorded
Phase 4	NCT06337253	Mar → May 2024	Plasmodium falciparum malaria	Malaria Consortium	Unknown	No outcome recorded
Phase 4	NCT05979896	Jul → Sep 2023	malaria	Malaria Consortium	Unknown	No outcome recorded
Phase 4	NCT05478954	Jul → Oct 2022	malaria	Malaria Consortium	Unknown	No outcome recorded
Phase 4	NCT04816461	Jul 2021 → Jun 2023	malaria	Institut de Recherche en Sciences de la Sante, Burkina Faso	Completed	No outcome recorded
Phase 4	NCT04829695	Apr → Dec 2021	Plasmodium falciparum malaria	University of Yaounde 1	Unknown	No outcome recorded
Phase 4	NCT04618523	Oct 2020 → Feb 2022	malaria	Ministry of Public Health, Democratic Republic of the Congo	Completed	No outcome recorded
Phase 4	NCT04565184	May 2019 → Nov 2020	Plasmodium falciparum malaria	University of Yaounde 1	Completed	No outcome recorded
Phase 4	NCT03773536	May → Sep 2017	Plasmodium falciparum malaria	Professor Anders Björkman	Completed	No outcome recorded
Phase 4	NCT02940756	Mar 2017 → Jan 2018	malaria	Ministry of Public Health, Democratic Republic of the Congo	Completed	No outcome recorded
Phase 4	NCT01697787	Oct 2012 → Sep 2014	Plasmodium falciparum malaria	Centre Muraz	Completed	No outcome recorded
Phase 4	NCT01651416	Jul → Dec 2012	anemia, malaria	Centre for Global Health Research, Ghana	Completed	No outcome recorded
Phase 4	NCT01023399	Nov 2009 → Oct 2013	malaria	Sanofi	Completed	No outcome recorded
Phase 4	NCT00902811	Dec 2008 → Oct 2009	Plasmodium falciparum malaria	Medecins Sans Frontieres, Netherlands	Unknown	No outcome recorded
Phase 4	NCT00712374	Sep 2008 → Dec 2011	malaria	London School of Hygiene and Tropical Medicine	Unknown	Missed primary
Phase 4	NCT00699920	Jun 2008 → Jun 2010	malaria	Sanofi	Completed	Met primary
Phase 4	NCT00540410	Sep 2007 → Feb 2009	Plasmodium falciparum malaria	Sanofi	Completed	No outcome recorded
Phase 4	NCT00465257	May 2007 → ?	malaria	Karolinska University Hospital	Suspended	No outcome recorded
Phase 4	NCT00425763	May → Aug 2007	malaria	Centers for Disease Control and Prevention	Completed	No outcome recorded
Phase 4	NCT00550160	Apr 2007 → May 2008	malaria	Kwame Nkrumah University of Science and Technology	Completed	No outcome recorded
Phase 4	NCT00376155	May 2006 → Feb 2007	malaria	London School of Hygiene and Tropical Medicine	Completed	Missed primary
Phase 4	NCT00238017	Oct → Dec 2005	malaria	Charite University, Berlin, Germany	Unknown	No outcome recorded
Phase 4	NCT00445796	Jun 2005 → ?	malaria	Sanofi	Completed	No outcome recorded
Phase 4	NCT00119145	Jun 2005 → May 2006	malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 4	NCT00164710	Apr → Sep 2005	Plasmodium falciparum malaria	Centers for Disease Control and Prevention	Completed	No outcome recorded
Phase 4	NCT00164359	Apr → Sep 2005	Plasmodium falciparum malaria	Centers for Disease Control and Prevention	Completed	No outcome recorded
Phase 4	NCT00137514	Mar 2001 → May 2004	Plasmodium falciparum malaria	Bandim Health Project	Completed	No outcome recorded
Phase 4	NCT01204411	—	Plasmodium falciparum malaria, protein-energy malnutrition	Epicentre	Withdrawn	No outcome recorded

Phase not applicable11 trials · 1 met primary · 1 missed
—	NCT06182176	May → Nov 2024	Nematoda infectious disease, malaria, schistosomiasis	London School of Hygiene and Tropical Medicine	Unknown	No outcome recorded
—	NCT04301531	Mar 2020 → Nov 2021	malaria	Noguchi Memorial Institute for Medical Research	Completed	No outcome recorded
—	NCT03035305	Aug → Nov 2016	malaria	Alliance for International Medical Action	Completed	No outcome recorded
—	NCT01634945	Apr 2012 → May 2013	anemia	Swiss Federal Institute of Technology	Completed	Missed primary
—	NCT01454752	Nov 2011 → Feb 2012	anemia, malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
—	NCT01326754	Aug 2011 → Jun 2012	Plasmodium falciparum malaria	Centers for Disease Control and Prevention	Completed	No outcome recorded
—	NCT00738946	Aug → Dec 2008	malaria	London School of Hygiene and Tropical Medicine	Completed	Met primary
—	NCT01567423	Apr 2008 → Apr 2009	Plasmodium falciparum malaria	Epicentre	Completed	No outcome recorded
—	NCT00157885	Jul → Dec 2005	Plasmodium falciparum malaria, Plasmodium vivax malaria	Menzies School of Health Research	Completed	No outcome recorded
—	NCT00127998	Jul 2005 → ?	malaria	Centers for Disease Control and Prevention	Completed	No outcome recorded
—	NCT00111163	Mar 2004 → Mar 2006	anemia, malaria	Centers for Disease Control and Prevention	Completed	Mixed

Comparator or background therapy37 trials
Phase 1/2	NCT00563914 Comparator	Oct 2007 → Nov 2008	malaria	Sanofi	Completed	No outcome recorded
Phase 2	NCT01955382 Background	Sep 2013 → Jul 2015	Plasmodium falciparum malaria	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	Missed primary
Phase 2	NCT01407887 Comparator	Aug 2011	Plasmodium falciparum malaria	Heidelberg University	Completed	No outcome recorded
Phase 2	NCT00545935 Comparator	Jul → Oct 2007	malaria	Heidelberg University	Completed	No outcome recorded
Phase 2	NCT00323622 Background	Apr 2005 → May 2007	malaria	GlaxoSmithKline	Completed	No outcome recorded
Phase 2/3	NCT02453308 Comparator	Aug 2015 → Mar 2018	Plasmodium falciparum malaria	University of Oxford	Completed	No outcome recorded
Phase 2/3	NCT00941785 Comparator	Jul → Dec 2009	malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 3	NCT06173206 Comparator	Jun → Dec 2024	malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 3	NCT03939104 Comparator	Jun 2021 → Jan 2023	Plasmodium falciparum malaria	University of Oxford	Completed	No outcome recorded
Phase 3	NCT04319380 Comparator	Apr 2020 → Mar 2022	Plasmodium falciparum malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 3	NCT04149106 Comparator	Jul 2019 → Dec 2022	Plasmodium falciparum malaria	University Clinical Research Center, Mali	Unknown	No outcome recorded
Phase 3	NCT03143218 Comparator	Apr 2017 → Mar 2020	Plasmodium falciparum malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 3	NCT02211729 Background	May 2014 → Dec 2017	malaria, respiratory tract infectious disorder	London School of Hygiene and Tropical Medicine	Completed	Missed primary
Phase 3	NCT01231113 Comparator	Jul 2011 → Dec 2012	Plasmodium falciparum malaria	Kwame Nkrumah University of Science and Technology	Completed	No outcome recorded
Phase 3	NCT01288820 Comparator	Jan 2011 → Apr 2012	Plasmodium vivax malaria	University of Oxford	Completed	No outcome recorded
Phase 3	NCT01152931 Comparator	Aug → Nov 2010	malaria	University of Lagos, Nigeria	Completed	No outcome recorded
Phase 3	NCT00944840 Comparator	Sep 2008 → Jul 2009	malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 3	NCT00852371 Comparator	Feb → Jun 2008	malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 3	NCT00529620 Comparator	Sep → Dec 2007	malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 3	NCT00297882 Comparator	Jul 2006 → Apr 2009	malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 4	NCT06300970 Comparator	Aug 2022 → Aug 2023	Plasmodium falciparum malaria	Centers for Disease Control and Prevention	Completed	No outcome recorded
Phase 4	NCT05323721 Comparator	Jun → Nov 2022	malaria	Malaria Consortium	Unknown	No outcome recorded
Phase 4	NCT05343312 Comparator	Mar 2022 → Sep 2023	Plasmodium falciparum malaria	Manhiça Health Research Centre	Completed	No outcome recorded
Phase 4	NCT05186363 Comparator	Jan → Jun 2022	malaria	Malaria Consortium	Unknown	No outcome recorded
Phase 4	NCT04370977 Comparator	Mar → Sep 2018	malaria	Manhiça Health Research Centre	Completed	No outcome recorded
Phase 4	NCT03178643 Comparator	Jan 2018 → Dec 2020	Plasmodium falciparum malaria	Duke University	Completed	No outcome recorded
Phase 4	NCT02741024 Comparator	Oct 2013 → Dec 2014	malaria	Medecins Sans Frontieres, Netherlands	Completed	No outcome recorded
Phase 4	NCT02168569 Comparator	Jun 2011 → Jan 2012	Plasmodium falciparum malaria	Manhiça Health Research Centre	Completed	No outcome recorded
Phase 4	NCT04877626 Comparator	Sep 2008 → Oct 2009	Plasmodium falciparum malaria	National University of Colombia	Completed	No outcome recorded
Phase 4	NCT00374205 Comparator	Sep 2006 → Oct 2007	Plasmodium falciparum malaria	Bernhard Nocht Institute for Tropical Medicine	Terminated	No outcome recorded
Phase 4	NCT03768908 Comparator	Jan → Jul 2005	Plasmodium falciparum malaria	Professor Anders Björkman	Completed	No outcome recorded
Phase 4	NCT03764527 Comparator	Nov 2002 → Feb 2003	Plasmodium falciparum malaria	Professor Anders Björkman	Completed	No outcome recorded
—	NCT05354258 Background	Jun → Nov 2022	Nematoda infectious disease, malaria, schistosomiasis	London School of Hygiene and Tropical Medicine	Unknown	No outcome recorded
—	NCT04238845 Background	Jul 2020 → Jul 2021	malaria, protein-energy malnutrition	Institut de Recherche en Sciences de la Sante, Burkina Faso	Unknown	No outcome recorded
—	NCT01967472 Comparator	Sep → Dec 2013	malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
—	NCT00460369 Comparator	Apr → Nov 2007	malaria	Research Institute for Development	Completed	No outcome recorded
—	NCT00285662 Comparator	Jun 2006 → May 2010	anemia, malaria	Papua New Guinea Institute of Medical Research	Completed	No outcome recorded

Evidence & citations 19 cited values

Every value below carries the sentence it was read from. 119 sources stand behind the page.

Field	Value	Cited text
Known as	Amodiaquine	“If the enzyme activity is normal and no other contra-indication for treatment are found, the participants will be treated with 14 days of primaquine 0.25mg/kg/day OR 7 days of...” NCT06923592 ↗ 116 “Patients received Cospherunate (50 mg Artésunate/125 mg Amodiaquine) at the rate of 2 tablets orally twice daily for 6 days and Azythromycine 250 mg orally at the rate of 2...” NCT04502342 ↗ “Artesunate-amodiaquine fixed dose combination (FDC) (Artesunate Amodiaquine Winthrop® Sanofi Aventis); Artesunate 25mg/amodiaquine 67.5mg; Artesunate 50mg/amodiaquine 135mg ;...” NCT00902811 ↗ “Following the recommendation of the WHO, Ghana changed its malaria treatment guidelines adopting artesunate and amodiaquine as first line for the treatment of uncomplicated...” NCT04301531 ↗ “Amodiaquine (10 mg/kg over 3 days) and Sulfadoxine Pyrimethamine (25 mg of sulfadoxine + 1.25 mg of pyrimethamine per kg in a single dose) or placebo administered over 3 rounds...” NCT00738946 ↗ “This preventive measures involves administering antimalarial drugs (Amodiaquine-Sulfadoxine-Pyrimethamine) to children aged 6- 59 months on a monthly basis during the high...” NCT04238845 ↗ “We will assess the efficacy of a three day course of amodiaquine plus three days of artesunate (AQ3/AS3) for the treatment of symptomatic, uncomplicated P. falciparum infections.” NCT00425763 ↗ “Artesunate 25mg / amodiaquine 67.5mg: 1 tab/day for 3 days in children 5 to 8.9 kg Artesunate 50mg / amodiaquine 135mg: 1 tab/day for 3 days in children 9 to 17.9 kg” NCT01567423 ↗ “One cycle of SMC consisting of sulphadoxine - pyrimethamine (SP) 500mg/25 mg, and amodiaquine (AQ) 150mg on day 1, and AQ 150mg on days 2 and 3.” NCT04319380 ↗ “Children will receive 500mg sulfadoxine plus 25mg pyrimethamine as one tablet, and 153mg amodiaquine (as hydrochloride) as one tablet on Day 0” NCT06173206 ↗ “Monthly administration of sulfadoxine-pyrimethamine plus amodiaquine, combined with community case management” NCT01449045 ↗ Show 106 more sources
Known as	Amodiaquin	ChEMBL registry synonym — accepted as the source's own label CHEMBL682 ↗
Known as	Amodiaquina	ChEMBL registry synonym — accepted as the source's own label CHEMBL682 ↗
Known as	Amodiaquine dihydrochloride dihydrate	ChEMBL registry synonym — accepted as the source's own label CHEMBL682 ↗
Known as	Amodiaquine hcl	ChEMBL registry synonym — accepted as the source's own label CHEMBL682 ↗
Known as	AMODIAQUINE HYDROCHLORIDE	ChEMBL registry synonym — accepted as the source's own label CHEMBL682 ↗
Known as	Amodiaquine hydrochloride dihydrate	ChEMBL registry synonym — accepted as the source's own label CHEMBL682 ↗
Known as	Amodiaquini hydrochloridum	ChEMBL registry synonym — accepted as the source's own label CHEMBL682 ↗
Known as	Amodiaquinum	ChEMBL registry synonym — accepted as the source's own label CHEMBL682 ↗
Known as	amodiquina	ClinicalTrials.gov intervention name — accepted as the source's own label NCT04877626 ↗
Known as	Camoquin hydrochloride	ChEMBL registry synonym — accepted as the source's own label CHEMBL682 ↗
Known as	GNF-Pf-5648	ChEMBL registry synonym — accepted as the source's own label CHEMBL682 ↗
Known as	NSC-13453	ChEMBL registry synonym — accepted as the source's own label CHEMBL682 ↗
Known as	NSC-755863	ChEMBL registry synonym — accepted as the source's own label CHEMBL682 ↗
Known as	SJ000110703	ChEMBL registry synonym — accepted as the source's own label CHEMBL682 ↗
Known as	Sunoquine	ChEMBL registry synonym — accepted as the source's own label CHEMBL682 ↗
Known as	TCMDC-123932	ChEMBL registry synonym — accepted as the source's own label CHEMBL682 ↗
Modality	Other / unclassified	“Artemisinin-based combination treatment” NCT04618523 ↗
Route	Oral	“25 mg/kg oral AQ over a period of three days” NCT00261222 ↗